Cargando…

Outcomes in patients with anthracycline‐induced cardiomyopathy undergoing left ventricular assist devices implantation

AIMS: Improved cancer survivorship has led to a higher number of anthracycline‐induced cardiomyopathy patients with end‐stage heart failure. We hypothesize that outcomes following continuous‐flow LVAD (CF‐LVAD) implantation in those with anthracycline‐induced cardiomyopathy are comparable with other...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guha, Avirup, Caraballo, Cesar, Jain, Prantesh, Miller, P. Elliott, Owusu‐Guha, Jocelyn, Clark, Katherine A.A., Velazquez, Eric J., Ahmad, Tariq, Baldassarre, Lauren A., Addison, Daniel, Weintraub, Neal L., Desai, Nihar R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318466/ https://www.ncbi.nlm.nih.gov/pubmed/33982867 http://dx.doi.org/10.1002/ehf2.13362

Ejemplares similares

Cardiovascular safety profile of taxanes and vinca alkaloids: 30 years FDA registry experience
por: Batra, Akshee, et al.
Publicado: (2021)

Cardiovascular Toxicities of Androgen Deprivation Therapy
por: Challa, Azariyas A., et al.
Publicado: (2021)

Brief report: Cannabis and opioid use disorder among heart failure admissions, 2008–2018
por: Chouairi, Fouad, et al.
Publicado: (2021)

National Trends in the Burden of Atrial Fibrillation During Hospital Admissions for Heart Failure
por: Reinhardt, Samuel W., et al.
Publicado: (2021)

Evaluation of Racial and Ethnic Disparities in Cardiac Transplantation
por: Chouairi, Fouad, et al.
Publicado: (2021)

Racial and Ethnic Differences in Cardiac Surveillance Evaluation of Patients Treated With Anthracycline‐Based Chemotherapy
por: DeRemer, David L., et al.
Publicado: (2023)

Multimodality Cardiac Imaging in the Era of Emerging Cancer Therapies
por: Biersmith, Michael A., et al.
Publicado: (2020)

Electrocardiograms for cardiomyopathy risk stratification in children with anthracycline exposure
por: Desai, Lajja, et al.
Publicado: (2019)

Cardiovascular adverse events associated with BRAF versus BRAF/MEK inhibitor: Cross‐sectional and longitudinal analysis using two large national registries
por: Guha, Avirup, et al.
Publicado: (2021)

Repurposing Immunomodulatory Therapies against Coronavirus Disease 2019 (COVID-19) in the Era of Cardiac Vigilance: A Systematic Review
por: Campbell, Courtney M., et al.
Publicado: (2020)

Pregnancy and Cardiomyopathy After Anthracyclines in Childhood
por: Thompson, Kara Annette
Publicado: (2018)

Cardio‐Oncology in the Era of the COVID‐19 Pandemic and Beyond
por: Addison, Daniel, et al.
Publicado: (2020)

Potential genetic predisposition for anthracycline-associated cardiomyopathy in families with dilated cardiomyopathy
por: Wasielewski, Marijke, et al.
Publicado: (2014)

Obesity and the Bidirectional Risk of Cancer and Cardiovascular Diseases in African Americans: Disparity vs. Ancestry
por: Guha, Avirup, et al.
Publicado: (2021)

Targeting Cardiovascular Adverse Events of Metastatic Renal Cell Carcinoma Therapies
por: Guha, Avirup, et al.
Publicado: (2022)

The Role of Carvedilol in the Treatment of Dilated and Anthracyclines-Induced Cardiomyopathy
por: Watanabe, Kenichi, et al.
Publicado: (2011)

Length of stay and cost of care associated with admissions for atrial fibrillation among patients with cancer
por: Guha, Avirup, et al.
Publicado: (2022)

Clinical implications of Type 2 diabetes on outcomes after cardiac transplantation
por: Chouairi, Fouad, et al.
Publicado: (2022)

Commentary: Longitudinal changes in circulating metabolites and lipoproteins after breast cancer treatment
por: Guha, Avirup, et al.
Publicado: (2022)

Impact of Obesity on Heart Transplantation Outcomes
por: Chouairi, Fouad, et al.
Publicado: (2021)

Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy
por: Nettersheim, Felix Sebastian, et al.
Publicado: (2023)

Pathological changes of the myocardium in reworsening of anthracycline-induced cardiomyopathy after explant of a left ventricular assist device
por: Hiraiwa, Hiroaki, et al.
Publicado: (2020)

Cardiovascular magnetic resonance characterization of left ventricular non-compaction provides independent prognostic information in patients with incident heart failure or suspected cardiomyopathy
por: Ashrith, Guha, et al.
Publicado: (2014)

Novel Cardiac Computed Tomography Methods for the Assessment of Anthracycline Induced Cardiotoxicity
por: Feher, Attila, et al.
Publicado: (2022)

Evaluating anthracycline cardiotoxicity associated single nucleotide polymorphisms in a paediatric cohort with early onset cardiomyopathy
por: McOwan, Timothy N., et al.
Publicado: (2020)

Clinical implications of differences between real world and clinical trial usage of left ventricular assist devices for end stage heart failure
por: Mezzacappa, Catherine, et al.
Publicado: (2020)

Anthracycline-induced cardiomyopathy: Is there a new light at the end of the tunnel?
por: Fradley, Michael G., et al.
Publicado: (2021)

Genetic Testing in Evaluating Risk of Anthracycline Cardiomyopathy: Are We There Yet?
por: Wong-Siegel, Jeannette R., et al.
Publicado: (2023)

Contemporary Trends and Outcomes of Percutaneous and Surgical Aortic Valve Replacement in Patients With Cancer
por: Guha, Avirup, et al.
Publicado: (2020)

Health care utilization and mortality associated with heart failure‐related admissions among cancer patients
por: Guha, Avirup, et al.
Publicado: (2019)

Hypertensive Cardiotoxicity in Cancer Treatment—Systematic Analysis of Adjunct, Conventional Chemotherapy, and Novel Therapies—Epidemiology, Incidence, and Pathophysiology
por: Chung, Robin, et al.
Publicado: (2020)

Molecular pathogenetic mechanisms and new therapeutic perspectives in anthracycline-induced cardiomyopathy
por: Distefano, Giuseppe
Publicado: (2009)

Cardiomyopathy in a dog with multicentric lymphoma following treatment with several anthracyclines
por: Tagawa, Michihito, et al.
Publicado: (2021)

Innovation in Precision Cardio-Oncology During the Coronavirus Pandemic and Into a Post-pandemic World
por: Brown, Sherry-Ann, et al.
Publicado: (2020)

Cardiovascular Toxicity of Novel HER2-Targeted Therapies in the Treatment of Breast Cancer
por: Dent, Susan F., et al.
Publicado: (2021)

How to Manage and Monitor Cardiac Dysfunction in Patients With Metastatic HER2-Positive Breast Cancer
por: Dent, Susan F., et al.
Publicado: (2022)

Editorial: Cancer treatment-related cardiovascular disease - real world data in cardio-oncology
por: Agarwala, Vivek, et al.
Publicado: (2023)

Left ventricular anatomy in obstructive hypertrophic cardiomyopathy: beyond basal septal hypertrophy
por: Hermida, Uxio, et al.
Publicado: (2022)

2693. Epidemiology of Infections with Multidrug-Resistant Organisms in Patients with Left Ventricular Assist Devices (LVADs)
por: Axell-House, Dierdre B, et al.
Publicado: (2023)

Extracellular matrix remodeling in animal models of anthracycline-induced cardiomyopathy: a meta-analysis
por: Leerink, Jan M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h0gkogtdufh5jab2r08i325tp6